JP2025505187A5 - - Google Patents

Info

Publication number
JP2025505187A5
JP2025505187A5 JP2024546277A JP2024546277A JP2025505187A5 JP 2025505187 A5 JP2025505187 A5 JP 2025505187A5 JP 2024546277 A JP2024546277 A JP 2024546277A JP 2024546277 A JP2024546277 A JP 2024546277A JP 2025505187 A5 JP2025505187 A5 JP 2025505187A5
Authority
JP
Japan
Prior art keywords
composition according
approximately
subject
per day
reduction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024546277A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025505187A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/062077 external-priority patent/WO2023150767A1/en
Publication of JP2025505187A publication Critical patent/JP2025505187A/ja
Publication of JP2025505187A5 publication Critical patent/JP2025505187A5/ja
Pending legal-status Critical Current

Links

JP2024546277A 2022-02-07 2023-02-06 体重減少の方法および骨格筋量を保存する方法 Pending JP2025505187A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263307506P 2022-02-07 2022-02-07
US63/307,506 2022-02-07
US202263382456P 2022-11-04 2022-11-04
US63/382,456 2022-11-04
PCT/US2023/062077 WO2023150767A1 (en) 2022-02-07 2023-02-06 Methods of weight loss and preserving skeletal muscle mass

Publications (2)

Publication Number Publication Date
JP2025505187A JP2025505187A (ja) 2025-02-21
JP2025505187A5 true JP2025505187A5 (cg-RX-API-DMAC7.html) 2026-02-16

Family

ID=85556813

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024546277A Pending JP2025505187A (ja) 2022-02-07 2023-02-06 体重減少の方法および骨格筋量を保存する方法

Country Status (12)

Country Link
US (1) US20250134864A1 (cg-RX-API-DMAC7.html)
EP (1) EP4475841A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025505187A (cg-RX-API-DMAC7.html)
KR (1) KR20240146052A (cg-RX-API-DMAC7.html)
AU (1) AU2023216366A1 (cg-RX-API-DMAC7.html)
CA (1) CA3243640A1 (cg-RX-API-DMAC7.html)
CL (1) CL2024002341A1 (cg-RX-API-DMAC7.html)
GE (1) GEAP202416578A (cg-RX-API-DMAC7.html)
IL (1) IL314684A (cg-RX-API-DMAC7.html)
JO (1) JOP20240177A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024009646A (cg-RX-API-DMAC7.html)
WO (1) WO2023150767A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025199516A1 (en) * 2024-03-22 2025-09-25 Board Of Regents, The University Of Texas System Compositions and methods for preserving or increasing lean muscle mass

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3565806T (pt) 2017-01-06 2022-05-19 Rivus Pharmaceuticals Inc Novos derivados de fenilo

Similar Documents

Publication Publication Date Title
JP7650929B2 (ja) 成人における焦点てんかんの処置のための合成経皮的カンナビジオール
US8071557B2 (en) Treatment of pulmonary hypertension with carbonic anhydrase inhibitors
JP3204320B2 (ja) あるシスチン誘導体の薬理学的使用
WO2012000377A1 (zh) 包含左卡尼汀和羟苯磺酸盐的药物组合物
US8653136B2 (en) Compositions based on amino acids for improving the myocardial ventricular function in patients suffering from diabetes
EP3226873B1 (en) Compositions comprising 15-hepe and its use for treating or preventing idiopathic pulomonary fibrosis
MX2023004812A (es) Composiciones de polvo seco de profarmacos de treprostinil y metodos de uso de estos.
JP2023549849A5 (cg-RX-API-DMAC7.html)
JP2024532957A5 (cg-RX-API-DMAC7.html)
JP2009534360A (ja) アルファ−ケトグルタレートを含む組成物およびその筋性能を調節するための使用
CA2620065A1 (en) Methods and formulations for modulating lyn kinase activity and treating related disorders
JP2025098147A5 (cg-RX-API-DMAC7.html)
JP2025505632A5 (cg-RX-API-DMAC7.html)
WO2018163119A1 (en) 1-piperidinepropionic acid for treating a fibrosing disease
JP4355967B2 (ja) 医薬組成物
EP0163683A1 (en) Chromone-2-carboxilic acid derivatives as cardiovascular agents
US20070066567A1 (en) Use of phospholipid arachidonic acids for increasing muscle mass in humans
WO2017126524A1 (ja) 糖尿病治療剤の併用
KR20240146052A (ko) 체중 감소 및 골격근 질량 보존 방법
TWI544928B (zh) 麥角固醇於製造藥劑之用途
JP5923044B2 (ja) 活性成分としてl−カルニチンまたはプロピオニルl−カルニチンを含む慢性静脈不全の予防または治療のための併用組成物
WO2026088203A1 (en) Synergistic composition for poor muscle health and sarcopenia
AU2014213552B2 (en) Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine
TR2021014613U5 (tr) DELİ BAL VE ORMAN GÜLÜ (Rhododendronlar) EKSTRELERİNİN ANTİ-HİPERTANSİF OLARAK KULLANIMI
WO2014171740A1 (ko) 아세클로페낙 또는 이의 약학적으로 허용 가능한 염과 위령선, 천화분 및 하고초를 포함하는 추출물을 포함하는 관절염의 치료 또는 개선용 약학 조성물